Sanli Jin1, Qian Lu2, Dong Pang1, Yan Sun3, Shaowen Xiao3, Baomin Zheng3, Hangjing Cui1. 1. Division of Medical & Surgical Nursing, School of Nursing, Peking University, #38 Xueyuan Road, Haidian District, Beijing, 100191, China. 2. Division of Medical & Surgical Nursing, School of Nursing, Peking University, #38 Xueyuan Road, Haidian District, Beijing, 100191, China. luqian@bjmu.edu.cn. 3. Department of Radiation Oncology, Peking University Cancer Hospital, #52 Fucheng Road, Haidian District, Beijing, 100142, China.
Abstract
PURPOSE: The Head and Neck Patient Symptom Checklist (HNSC) is a valid tool for measuring nutrition impact symptoms (NIS) specific to head and neck cancer (HNC) patients. This study aimed to translate the HNSC into Chinese and to evaluate its psychometric properties in Chinese HNC patients treated with radiotherapy. METHODS: The HNSC was translated into Chinese following standard forward- and back-translation procedures. Three instruments, the Chinese version of HNSC, the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, and Patient-Generated Subjective Global Assessment (PG-SGA), were answered by 116 HNC patients, of whom 11 were submitted to the test-retest in 3-7 days. The criterion and convergent validities were confirmed by measuring the relations of the HNSC score with the PG-SGA and EORTC QLQ-C30, respectively. The discriminant validity was evaluated through known group analysis. Reliability was evaluated by means of Cronbach's alpha and test-retest using the correlation coefficient. RESULTS: Criterion validity was 0.767 for intensity dimension and 0.795 for interference dimension, respectively. Convergent validity was confirmed by the significant correlations between the HHSC score and most domains of QLQ-C30. The comparison among the groups demonstrated good discriminant validity. The Cronbach's alpha was 0.787 for intensity dimension and 0.797 for interference dimension, respectively. The test-retest reliability was 0.845 for intensity dimension and 0.883 for interference dimension, respectively. CONCLUSIONS: The Chinese version of HNSC demonstrated favorable validity and reliability. It can be used in identification of NIS and development of symptom management program in HNC patients in China.
PURPOSE: The Head and Neck Patient Symptom Checklist (HNSC) is a valid tool for measuring nutrition impact symptoms (NIS) specific to head and neck cancer (HNC) patients. This study aimed to translate the HNSC into Chinese and to evaluate its psychometric properties in Chinese HNC patients treated with radiotherapy. METHODS: The HNSC was translated into Chinese following standard forward- and back-translation procedures. Three instruments, the Chinese version of HNSC, the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, and Patient-Generated Subjective Global Assessment (PG-SGA), were answered by 116 HNC patients, of whom 11 were submitted to the test-retest in 3-7 days. The criterion and convergent validities were confirmed by measuring the relations of the HNSC score with the PG-SGA and EORTC QLQ-C30, respectively. The discriminant validity was evaluated through known group analysis. Reliability was evaluated by means of Cronbach's alpha and test-retest using the correlation coefficient. RESULTS: Criterion validity was 0.767 for intensity dimension and 0.795 for interference dimension, respectively. Convergent validity was confirmed by the significant correlations between the HHSC score and most domains of QLQ-C30. The comparison among the groups demonstrated good discriminant validity. The Cronbach's alpha was 0.787 for intensity dimension and 0.797 for interference dimension, respectively. The test-retest reliability was 0.845 for intensity dimension and 0.883 for interference dimension, respectively. CONCLUSIONS: The Chinese version of HNSC demonstrated favorable validity and reliability. It can be used in identification of NIS and development of symptom management program in HNC patients in China.
Entities:
Keywords:
Head and Neck Patient Symptom Checklist; Head and neck cancer; Nutrition impact symptom; Reliability; Validity
Authors: Antonio Schindler; Nerina Denaro; Elvio G Russi; Nicole Pizzorni; Paolo Bossi; Anna Merlotti; Massimo Spadola Bissetti; Gianmauro Numico; Alessandro Gava; Ester Orlandi; Orietta Caspiani; Michela Buglione; Daniela Alterio; Almalina Bacigalupo; Vitaliana De Sanctis; Giovanni Pavanato; Carla Ripamonti; Marco C Merlano; Lisa Licitra; Giuseppe Sanguineti; Johannes A Langendijk; Barbara Murphy Journal: Crit Rev Oncol Hematol Date: 2015-06-19 Impact factor: 6.312
Authors: Barbara A Murphy; Mary S Dietrich; Nancy Wells; Kathleen Dwyer; Sheila H Ridner; Heidi J Silver; Jill Gilbert; Christine H Chung; Anthony Cmelak; Brian Burkey; Wendell G Yarbrough; Robert Sinard; James Netterville Journal: Head Neck Date: 2010-01 Impact factor: 3.147
Authors: Catherine Kubrak; Kärin Olson; Naresh Jha; Louise Jensen; Linda McCargar; Hadi Seikaly; Jeffery Harris; Rufus Scrimger; Matthew Parliament; Vickie E Baracos Journal: Head Neck Date: 2010-03 Impact factor: 3.147
Authors: Vitaliana De Sanctis; Paolo Bossi; Giuseppe Sanguineti; Fabio Trippa; Daris Ferrari; Almalina Bacigalupo; Carla Ida Ripamonti; Michela Buglione; Stefano Pergolizzi; Johannes A Langendjik; Barbara Murphy; Judith Raber-Durlacher; Elvio G Russi; Rajesh V Lalla Journal: Crit Rev Oncol Hematol Date: 2016-02-01 Impact factor: 6.312
Authors: David I Rosenthal; Tito R Mendoza; Mark S Chambers; V Shannon Burkett; Adam S Garden; Amy C Hessell; Jan S Lewin; K Kian Ang; Merrill S Kies; Ibrahima Gning; Xin S Wang; Charles S Cleeland Journal: Int J Radiat Oncol Biol Phys Date: 2008-05-22 Impact factor: 7.038
Authors: J A E Langius; S Bakker; D H F Rietveld; H M Kruizenga; J A Langendijk; P J M Weijs; C R Leemans Journal: Br J Cancer Date: 2013-08-08 Impact factor: 7.640